These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 1678501

  • 1. Chronic eticlopride and dopamine denervation induce equal nonadditive increases in striatal D2 receptor density: autoradiographic evidence against the dual mechanism hypothesis.
    LaHoste GJ, Marshall JF.
    Neuroscience; 1991; 41(2-3):473-81. PubMed ID: 1678501
    [Abstract] [Full Text] [Related]

  • 2. Non-additivity of D2 receptor proliferation induced by dopamine denervation and chronic selective antagonist administration: evidence from quantitative autoradiography indicates a single mechanism of action.
    LaHoste GJ, Marshall JF.
    Brain Res; 1989 Nov 20; 502(2):223-32. PubMed ID: 2531015
    [Abstract] [Full Text] [Related]

  • 3. Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists.
    LaHoste GJ, Marshall JF.
    Behav Brain Res; 1990 May 28; 38(3):233-42. PubMed ID: 1973041
    [Abstract] [Full Text] [Related]

  • 4. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan 28; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

  • 5. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT, White FJ.
    Synapse; 1992 Mar 28; 10(3):206-16. PubMed ID: 1532677
    [Abstract] [Full Text] [Related]

  • 6. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ, Marshall JF.
    Synapse; 1992 Sep 28; 12(1):14-26. PubMed ID: 1357762
    [Abstract] [Full Text] [Related]

  • 7. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding.
    Engber TM, Marin C, Susel Z, Chase TN.
    Eur J Pharmacol; 1993 Jun 04; 236(3):385-93. PubMed ID: 8102970
    [Abstract] [Full Text] [Related]

  • 8. Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation.
    Thomas KL, Rose S, Jenner P, Marsden CD.
    Biochem Pharmacol; 1992 Jul 07; 44(1):73-82. PubMed ID: 1321630
    [Abstract] [Full Text] [Related]

  • 9. Lesions of the nigrostriatal dopamine projection increase the inhibitory effects of D1 and D2 dopamine agonists on caudate-putamen neurons and relieve D2 receptors from the necessity of D1 receptor stimulation.
    Hu XT, Wachtel SR, Galloway MP, White FJ.
    J Neurosci; 1990 Jul 07; 10(7):2318-29. PubMed ID: 1973947
    [Abstract] [Full Text] [Related]

  • 10. Autoradiographic identification of D1 dopamine receptors labelled with [3H]dopamine: distribution, regulation and relationship to coupling.
    Hervé D, Trovero F, Blanc G, Glowinski J, Tassin JP.
    Neuroscience; 1992 Jul 07; 46(3):687-700. PubMed ID: 1532052
    [Abstract] [Full Text] [Related]

  • 11. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT, White FJ.
    Synapse; 1994 May 07; 17(1):43-61. PubMed ID: 7913772
    [Abstract] [Full Text] [Related]

  • 12. Decreased striatal D1 binding density following mesotelencephalic 6-hydroxydopamine injections: an autoradiographic analysis.
    Marshall JF, Navarrete R, Joyce JN.
    Brain Res; 1989 Jul 31; 493(2):247-57. PubMed ID: 2527583
    [Abstract] [Full Text] [Related]

  • 13. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
    Giorgi O, Biggio G.
    Brain Res; 1990 Nov 12; 533(1):53-9. PubMed ID: 1982234
    [Abstract] [Full Text] [Related]

  • 14. Differential regulation of striatal preproenkephalin mRNA by D1 and D2 dopamine receptors.
    Pollack AE, Wooten GF.
    Brain Res Mol Brain Res; 1992 Jan 12; 12(1-3):111-9. PubMed ID: 1312196
    [Abstract] [Full Text] [Related]

  • 15. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
    Subramaniam S, Lucki I, McGonigle P.
    Brain Res; 1992 Feb 07; 571(2):313-22. PubMed ID: 1351781
    [Abstract] [Full Text] [Related]

  • 16. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
    Puschban Z, Scherfler C, Granata R, Laboyrie P, Quinn NP, Jenner P, Poewe W, Wenning GK.
    Neuroscience; 2000 Feb 07; 95(2):377-88. PubMed ID: 10658617
    [Abstract] [Full Text] [Related]

  • 17. Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. I. 6-OHDA lesions of ascending mesencephalic dopaminergic pathways in the rat.
    Graham WC, Crossman AR, Woodruff GN.
    Brain Res; 1990 Apr 23; 514(1):93-102. PubMed ID: 2113410
    [Abstract] [Full Text] [Related]

  • 18. Dopamine D2 receptor control of pallidal fos expression: comparisons between intact and 6-hydroxydopamine-treated hemispheres.
    Marshall JF, Cole BN, LaHoste GJ.
    Brain Res; 1993 Dec 31; 632(1-2):308-13. PubMed ID: 7908600
    [Abstract] [Full Text] [Related]

  • 19. Role of N-methyl-D-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems.
    Singh NA, Bush LG, Gibb JW, Hanson GR.
    Brain Res; 1992 Feb 07; 571(2):260-4. PubMed ID: 1351780
    [Abstract] [Full Text] [Related]

  • 20. Differential modulation of striatonigral dynorphin and enkephalin by dopamine receptor subtypes.
    Jiang HK, McGinty JF, Hong JS.
    Brain Res; 1990 Jan 15; 507(1):57-64. PubMed ID: 1967976
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.